| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Meeting Report |
Department of Pediatrics, Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 [J. A. B.]; Albert Einstein College of Medicine, Bronx, New York 10461 [G. K.]; University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 [E. S. K.]; Children's National Medical Center, Washington, D.C. 20010 [R. J. P.]; Dana Farber Cancer Institute, Boston, Massachusetts 02115 [C. W. M. R.]; National Cancer Institute, Bethesda, Maryland 20892 [C. J. T., M. S.]; and University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 [B. W.]
ABSTRACT
A workshop on childhood atypical teratoid/rhabdoid tumors of the central nervous system, sponsored by the National Cancer Institute and the Pediatric Brain Tumor Foundation of the United States, was held on January 29, 2001 in Bethesda, Maryland. Drs. Malcolm Smith, Jaclyn Biegel, and Roger Packer hosted the meeting. There were 22 participants from 14 institutions. The sessions were designed to review what was known about the biology and clinical behavior of rhabdoid tumors and to begin to develop treatment strategies that might be effective against this clinically aggressive group of malignancies. This report summarizes the biology sessions from the meeting. A detailed summary of the discussions regarding diagnostic studies and the roles for radiation therapy, chemotherapy, and bone marrow or stem cell transplant in the treatment of rhabdoid tumors will be published separately.
This article has been cited by other articles:
|
|
 |
|
  A. Morozov, S. J. Lee, Z.-K. Zhang, V. Cimica, D. Zagzag, and G. V. Kalpana INI1 Induces Interferon Signaling and Spindle Checkpoint in Rhabdoid Tumors Clin. Cancer Res., August 15, 2007; 13(16): 4721 - 4730. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. B. Zraly, F. A. Middleton, and A. K. Dingwall Hormone-response Genes Are Direct in Vivo Regulatory Targets of Brahma (SWI/SNF) Complex Function J. Biol. Chem., November 17, 2006; 281(46): 35305 - 35315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Guidi, R. Mudhasani, K. Hoover, A. Koff, I. Leav, A. N. Imbalzano, and S. N. Jones Functional Interaction of the Retinoblastoma and Ini1/Snf5 Tumor Suppressors in Cell Growth and Pituitary Tumorigenesis Cancer Res., August 15, 2006; 66(16): 8076 - 8082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chai, A. L. Charboneau, B. L. Betz, and B. E. Weissman Loss of the hSNF5 Gene Concomitantly Inactivates p21CIP/WAF1 and p16INK4a Activity Associated with Replicative Senescence in A204 Rhabdoid Tumor Cells Cancer Res., November 15, 2005; 65(22): 10192 - 10198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tsikitis, Z. Zhang, W. Edelman, D. Zagzag, and G. V. Kalpana Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss PNAS, August 23, 2005; 102(34): 12129 - 12134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Hilden, S. Meerbaum, P. Burger, J. Finlay, A. Janss, B. W. Scheithauer, A. W. Walter, L. B. Rorke, and J. A. Biegel Central Nervous System Atypical Teratoid/Rhabdoid Tumor: Results of Therapy in Children Enrolled in a Registry J. Clin. Oncol., July 15, 2004; 22(14): 2877 - 2884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Biegel, L. Tan, F. Zhang, L. Wainwright, P. Russo, and L. B. Rorke Alterations of the hSNF5/INI1 Gene in Central Nervous System Atypical Teratoid/Rhabdoid Tumors and Renal and Extrarenal Rhabdoid Tumors Clin. Cancer Res., November 1, 2002; 8(11): 3461 - 3467. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
